What is Syndax Pharmaceuticals's G&A?

Syndax Pharmaceuticals (SNDX) reported G&A of $37.59M in Q1 2026.

How has Syndax Pharmaceuticals's G&A changed year-over-year?

Syndax Pharmaceuticals's G&A decreased by 8.4% year-over-year, from $41.03M to $37.59M.

Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.

Syndax Pharmaceuticals SNDX G&A

G&A at other companies

SELLAS Life Sciences Group, Inc.SLS

$4.12M+44.3%

ArriVent BioPharma, Inc.AVBP

$8.49M+54.9%

ImmunomeIMNM

$12.95M+21.1%

Arcus BiosciencesRCUS

$29M+3.6%

Enliven TherapeuticsELVN

$7.14M+5.0%

Ligand PharmaceuticalsLGND

$20.84M+10.8%

Other financials

Income statement

See full

Revenue$64.9M+224%

Operating income-$34.2M+59.2%

Net income-$42.7M+49.7%

EPS (diluted)-$0.48+51.0%

Balance sheet

See full

Cash & equivalents$130.9M-15.0%

Total debt$350.5M+4.2%

Total equity$41.6M-80.6%

Total assets$472.7M-26.2%

Cash flow

See full

Operating cash flow-$50.3M+47.1%

CapEx$46.8K—

Free cash flow-$80.8M-17.6%

Valuation

See full

Market cap$1.74B+95.0%

Enterprise value$1.96B+84.0%

P/S8×-12.4×

Profitability

See full

Operating margin-102.8%-47.8pp

Net margin-111.9%-51.5pp

FCF margin-187.2%-85.4pp

Returns & leverage

See full

Return on equity-189.5%-8,509pp

Debt / equity8.4×+6.9×

Current ratio5.5×-0.3×

Where this comes from

Reported directly by Syndax Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Syndax Pharmaceuticals's g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Syndax Pharmaceuticals's G&A?: Syndax Pharmaceuticals (SNDX) reported G&A of $37.59M in Q1 2026.
How has Syndax Pharmaceuticals's G&A changed year-over-year?: Syndax Pharmaceuticals's G&A decreased by 8.4% year-over-year, from $41.03M to $37.59M.
What does G&A mean?: Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.